Ardashev V N, Sokolianskiĭ N V, Bystrov V V
Klin Med (Mosk). 2000;78(12):28-30.
Changes in clinical and hemodynamic indices, hemostatic system during therapy with plasminogen tissue activator and streptokinase drugs were studied in 49 patients with massive and submassive forms of pulmonary thromboembolism. Conduction of fibrinolytic therapy with plasminogen tissue activator vs streptokinase produced more marked and rapid change in the main hemodynamic parameters which characterized blood recovery in pulmonary artery. A correlation was revealed between the change in hemostatic system after thrombolytic therapy and development of hemorrhagic complications. Preferable introduction of plasminogen tissue activator is shown when thromboemboli locate in the trunk or in both main pulmonary arteries and in the presence of an occlusive lesion in lobular arteries.
对49例大面积和次大面积肺血栓栓塞症患者,研究了在使用组织型纤溶酶原激活剂和链激酶药物治疗期间临床和血流动力学指标、止血系统的变化。与链激酶相比,使用组织型纤溶酶原激活剂进行纤溶治疗时,主要血流动力学参数的变化更显著、更迅速,这些参数表征了肺动脉血流的恢复。溶栓治疗后止血系统的变化与出血并发症的发生之间存在相关性。当血栓栓子位于主干或双侧主肺动脉,以及小叶动脉存在闭塞性病变时,显示优先使用组织型纤溶酶原激活剂。